Genocea Biosciences reported $24.41M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agenus AGEN:US $ 288.93M 1.55M
Baxter International BAX:US $ 7882M 291M
Bluebird Bio BLUE:US $ 167.46M 87.46M
Cytokinetics CYTK:US $ 602.25M 21.28M
Cytori Therapeutics CYTX:US $ 18.89M 3.22M
Genocea Biosciences GNCA:US $ 24.41M 17.41M
Glaxosmithkline GSK:US $ 54188M 25200M
Infinity Pharmaceuticals INFI:US $ 59.61M 10.49M
Mirati Therapeutics MRTX:US $ 1202.93M 140.19M
Moderna Inc MRNA:US 13.56B 2.79B
Novavax NVAX:US $ 2136M 211.4M
Prothena PRTA:US 521.29M 34.33M